NEU neuren pharmaceuticals limited

Ann: 2023 Results webinar, page-29

  1. 5,808 Posts.
    lightbulb Created with Sketch. 759
    I wasn't able to listen in but will do so when I can.
    The most important thing for me was feedback on his demeanour when discussing the upcoming trial results of Pitt-Hopkins and Angelman.
    He was always very upbeat about Phelan and we saw why when the outstanding results came out.
    Some have briefly mentioned a degree of positivity today when discussing up coming results.
    I am hoping to pick that up as well when I listen later.
    The positive Phelan results was such a de-risker but continued success in the upcoming trials will be incredibly defining.
    It will show success in condition after condition revealing proof of untapped discovery.
    I believe some also mentioned that Jon mentioned about the possibility of other conditions.
    This is incredibly exciting and the bullshit Culper report will fall into vast void of insignificance.
    Well done Jon and the team once again.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$12.54
Change
0.100(0.80%)
Mkt cap ! $1.559B
Open High Low Value Volume
$12.44 $12.73 $12.13 $11.07M 885.6K

Buyers (Bids)

No. Vol. Price($)
1 1215 $12.52
 

Sellers (Offers)

Price($) Vol. No.
$12.54 804 1
View Market Depth
Last trade - 16.10pm 20/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.